文献速递焦虑、强迫与应激相关障碍

伽玛刀囊切开术治疗难治性强迫症的演进

Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder.
PubMed 文献 · Mol Psychiatry · 2018-05-09

本文系统综述了伽玛刀囊切开术(GKC)治疗难治性强迫症(OCD)的历史与进展。该手术从诞生到现代改良,不良事件已显著减少,在经验丰富的中心约二分之一至三分之二的患者仍可获得良好应答,认知功能未见受损甚至部分改善。现代伽玛刀腹侧囊切开术仍是高度难治性OCD选定病例的可靠选择。

要点

  • GKC适用于经充分药物和心理治疗仍难治的严重OCD患者。
  • 经验丰富中心约1/2至2/3患者可获得良好应答。
  • 新剂量与靶向策略使额叶水肿和放射性坏死囊肿等并发症明显减少。

核心结论

  • GKC及其现代变体伽玛刀腹侧囊切开术仍是选定高度难治性OCD病例的可靠治疗选择。
  • 减少强迫症状严重度可能源于直接调节OCD神经通路及与药物心理治疗协同增强疗效。

研究设计与样本

  • 本文为系统综述,检索现有文献并对GKC手术演进进行叙述性回顾。
  • 综述涵盖从手术起源到近期进展的历史,并讨论未来试验设计、靶向与剂量规划优化及先进影像应用。

主要发现

  • 在经验丰富中心治疗的患者中,约二分之一至三分之二可获得良好应答。
  • 随着手术演进,不良事件已显著减少。
  • 近期研究的详细神经心理学评估提示认知功能未受损,部分领域可能改善。

关键数值与推荐

  • 手术候选者需经广泛、适当的药物和心理治疗仍难治的严重OCD患者。
  • 可能并发症包括额叶水肿和罕见的迟发性放射性坏死囊肿,新辐射剂量与靶向策略已使其更少见。

临床怎么用

  • GKC应仅用于经充分药物和心理治疗仍难治的严重OCD选定病例。
  • 治疗应在经验丰富的中心进行,并采用优化靶向与剂量规划以减少不良事件。
  • 术后可预期与药物心理治疗协同增强疗效,并需监测额叶水肿等并发症。

局限性

  • 可靠的结果预测因素仍难以确定。
  • 未来试验设计需考虑GKC治疗的独特特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For more than half a century, stereotactic neurosurgical procedures have been available to treat patients with severe, debilitating symptoms of obsessive-compulsive disorder (OCD) that have proven refractory to extensive, appropriate pharmacological, and psychological treatment. Although reliable predictors of outcome remain elusive, the establishment of narrower selection criteria for neurosurgical candidacy, together with a better understanding of the functional neuroanatomy implicated in OCD, has resulted in improved clinical efficacy for an array of ablative and non-ablative intervention techniques targeting the cingulum, internal capsule, and other limbic regions. It was against this backdrop that gamma knife capsulotomy (GKC) for OCD was developed. In this paper, we review the history of this stereotactic radiosurgical procedure, from its inception to recent advances. We perform a systematic review of the existing literature and also provide a narrative account of the evolution of the procedure, detailing how the procedure has changed over time, and has been shaped by forces of evidence and innovation. As the procedure has evolved and adverse events have decreased considerably, favorable response rates have remained attainable for approximately one-half to two-thirds of individuals treated at experienced centers. A reduction in obsessive-compulsive symptom severity may result not only from direct modulation of OCD neural pathways but also from enhanced efficacy of pharmacological and psychological therapies working in a synergistic fashion with GKC. Possible complications include frontal lobe edema and even the rare formation of delayed radionecrotic cysts. These adverse events have become much less common with new radiation dose and targeting strategies. Detailed neuropsychological assessments from recent studies suggest that cognitive function is not impaired, and in some domains may even improve following treatment. We conclude this review with discussions covering topics essential for further progress of this therapy, including suggestions for future trial design given the unique features of GKC therapy, considerations for optimizing stereotactic targeting and dose planning using biophysical models, and the use of advanced imaging techniques to understand circuitry and predict response. GKC, and in particular its modern variant, gamma ventral capsulotomy, continues to be a reliable treatment option for selected cases of otherwise highly refractory OCD.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Miguel EC, Lopes AC, McLaughlin NCR, et al. Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder. Mol Psychiatry. 2018. PMID: 29743581. doi:10.1038/s41380-018-0054-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。